Here are five key facts:
1. RBC Capital has an “outperform” rating on Stryker shares.
2. Stryker has a market cap of $40.84 billion.
2. The P/E ratio is 28.97.
4. The company’s 52-week low is $86.68 and 52-week high is $113.85.
5. For the first quarter of 2016, Stryker reported net earnings reaching $402 million, up $79.5 million in the first quarter the year prior.
More device news:
Stryker’s net earnings up 79.5%; Orthopedics sales reach $1.1B: 9 key notes on Q1 2016
FDA clears Exatech’s Vantage Total Ankle — 5 highlights
Medtech’s ROSA system to be featured at AANS annual meeting — 3 quick notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
